Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 5
1967 3
1968 7
1969 2
1970 7
1971 7
1972 3
1973 9
1974 7
1975 8
1976 25
1977 5
1978 6
1979 8
1980 3
1981 11
1982 9
1983 7
1984 5
1985 6
1986 6
1987 5
1988 8
1989 6
1990 4
1991 8
1992 6
1993 7
1994 7
1995 38
1996 63
1997 63
1998 61
1999 101
2000 97
2001 94
2002 108
2003 133
2004 111
2005 125
2006 172
2007 130
2008 175
2009 154
2010 135
2011 158
2012 168
2013 182
2014 191
2015 177
2016 199
2017 226
2018 255
2019 115
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

3,329 results
Results by year
Filters applied: . Clear all
Page 1
Low Dose Naltrexone in the Treatment of Fibromyalgia.
Metyas S, Chen CL, Yeter K, Solyman J, Arkfeld DG. Metyas S, et al. Curr Rheumatol Rev. 2018;14(2):177-180. doi: 10.2174/1573397113666170321120329. Curr Rheumatol Rev. 2018. PMID: 28325149 Clinical Trial.
The uses of naltrexone in dermatologic conditions.
Lee B, Elston DM. Lee B, et al. J Am Acad Dermatol. 2019 Jun;80(6):1746-1752. doi: 10.1016/j.jaad.2018.12.031. Epub 2018 Dec 21. J Am Acad Dermatol. 2019. PMID: 30582992 Review.
Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?
Victorri-Vigneau C, Spiers A, Caillet P, Bruneau M, Ignace-Consortium, Challet-Bouju G, Grall-Bronnec M. Victorri-Vigneau C, et al. Curr Neuropharmacol. 2018;16(10):1418-1432. doi: 10.2174/1570159X15666170718144058. Curr Neuropharmacol. 2018. PMID: 28721822 Free PMC article. Review.
Naloxone treatment in opioid addiction: the risks and benefits.
van Dorp E, Yassen A, Dahan A. van Dorp E, et al. Expert Opin Drug Saf. 2007 Mar;6(2):125-32. doi: 10.1517/14740338.6.2.125. Expert Opin Drug Saf. 2007. PMID: 17367258 Review.
Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.
Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, Grusing S, Devine B, Chou R. Korthuis PT, et al. Ann Intern Med. 2017 Feb 21;166(4):268-278. doi: 10.7326/M16-2149. Epub 2016 Dec 6. Ann Intern Med. 2017. PMID: 27919103 Free PMC article. Review.
Take-home naloxone in Australia and beyond.
Olsen A, Dwyer R, Lenton S. Olsen A, et al. Drug Alcohol Rev. 2018 May;37(4):437-439. doi: 10.1111/dar.12700. Drug Alcohol Rev. 2018. PMID: 29744978 No abstract available.
Medication-Assisted Treatment of Adolescents With Opioid Use Disorders.
COMMITTEE ON SUBSTANCE USE AND PREVENTION. COMMITTEE ON SUBSTANCE USE AND PREVENTION. Pediatrics. 2016 Sep;138(3):e20161893. doi: 10.1542/peds.2016-1893. Epub 2016 Aug 22. Pediatrics. 2016. PMID: 27550978 Free article. Review.
Sublocade: The Once-Monthly Buprenorphine Injectable.
J Addict Nurs. 2018 Apr/Jun;29(2):139-140. doi: 10.1097/JAN.0000000000000223. J Addict Nurs. 2018. PMID: 29864061 No abstract available.
3,329 results
Jump to page
Feedback